These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7637723)

  • 1. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation.
    Keogh A; Spratt P; McCosker C; Macdonald P; Mundy J; Kaan A
    N Engl J Med; 1995 Sep; 333(10):628-33. PubMed ID: 7637723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of inhaled cyclosporine in lung-transplant recipients.
    Iacono AT; Johnson BA; Grgurich WF; Youssef JG; Corcoran TE; Seiler DA; Dauber JH; Smaldone GC; Zeevi A; Yousem SA; Fung JJ; Burckart GJ; McCurry KR; Griffith BP
    N Engl J Med; 2006 Jan; 354(2):141-50. PubMed ID: 16407509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation.
    Butman SM; Wild JC; Nolan PE; Fagan TC; Finley PR; Hicks MJ; Mackie MJ; Copeland JG
    J Heart Lung Transplant; 1991; 10(3):351-8. PubMed ID: 1854763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.
    Barr ML; Meiser BM; Eisen HJ; Roberts RF; Livi U; Dall'Amico R; Dorent R; Rogers JG; Radovancević B; Taylor DO; Jeevanandam V; Marboe CC
    N Engl J Med; 1998 Dec; 339(24):1744-51. PubMed ID: 9845709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of cyclosporine in renal-transplant recipients.
    Burke JF; Pirsch JD; Ramos EL; Salomon DR; Stablein DM; Van Buren DH; West JC
    N Engl J Med; 1994 Aug; 331(6):358-63. PubMed ID: 8028616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids.
    Kobashigawa J; David K; Morris J; Chu AH; Steffen BJ; Gotz VP; Gordon RD
    Transplant Proc; 2005 Mar; 37(2):1333-9. PubMed ID: 15848713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus versus azathioprine in a cyclosporine and ketoconazole-based immunosuppressive therapy in kidney transplant: 3-year follow-up of an open-label, prospective, cohort, comparative clinical trial.
    Gonzalez F; Espinoza M; Herrera P; Rocca X; Reynolds E; Lorca E; Roessler E; Hidalgo J; Espinoza O
    Transplant Proc; 2010; 42(1):270-2. PubMed ID: 20172327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA; Patel J; Furukawa H; Moriguchi JD; Yeatman L; Takemoto S; Marquez A; Shaw J; Oeser BT; Subherwal S; Wu GW; Kawano J; Laks H
    J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.
    Beniaminovitz A; Itescu S; Lietz K; Donovan M; Burke EM; Groff BD; Edwards N; Mancini DM
    N Engl J Med; 2000 Mar; 342(9):613-9. PubMed ID: 10699160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
    Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
    Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
    J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine reduction in the presence of everolimus: 3-month data from a Canadian pilot study of maintenance cardiac allograft recipients.
    Ross H; Pflugfelder P; Haddad H; Cantarovich M; White M; Ignaszewski A; Howlett J; Vaillancourt M; Dorent R; Burton JR;
    J Heart Lung Transplant; 2008 Feb; 27(2):197-202. PubMed ID: 18267227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cyclosporine and tacrolimus in combination with rabbit antithymocyte immunoglobulins as induction therapy in cardiac transplantation.
    Jacques F; Carrier M; Pelletier GB; Racine N; White M; Perrault LP; Pellerin M
    Transplant Proc; 2009 Oct; 41(8):3337-41. PubMed ID: 19857745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart transplantation in females.
    Esmore D; Keogh A; Spratt P; Jones B; Chang V
    J Heart Lung Transplant; 1991; 10(3):335-41. PubMed ID: 1854761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulation blockade with belatacept in renal transplantation.
    Vincenti F; Larsen C; Durrbach A; Wekerle T; Nashan B; Blancho G; Lang P; Grinyo J; Halloran PF; Solez K; Hagerty D; Levy E; Zhou W; Natarajan K; Charpentier B;
    N Engl J Med; 2005 Aug; 353(8):770-81. PubMed ID: 16120857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose cyclosporine treatment fails to prevent coronary luminal narrowing after heart transplantation.
    Vassalli G; Kaski JC; Tousoulis D; Kiowski W; Turina M; Follath F; Gallino A
    J Heart Lung Transplant; 1996 Jun; 15(6):612-9. PubMed ID: 8794036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant treatment with ursodeoxycholic acid may reduce the incidence of acute cardiac allograft rejection.
    Bährle S; Szabó G; Stiehl A; Theilmann L; Dengler TJ; Zimmermann R; Kübler W
    J Heart Lung Transplant; 1998 Jun; 17(6):592-8. PubMed ID: 9662095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.